Overall performance of the indian pharmaceuticals industry

April 2007
Drugs and Pharmaceuticals
Industry Highlights
Chapter Page
− US congress considers new bill for generic drugs − Drug discovery and development: An Indian − Merck cuts anti-aids drug price − Climate change to hit the pharmaceutical News & Views
− Merck cuts price of once daily HIV drug Industry News 5
− Indonesia agrees to share flu virus sample with − Pharma industry mixed reaction to budget − NPIL to invest $50 mn in new facilities − Ranbaxy gets regulatory nod in Romania Healthcare News
Pharma sector sets for double digit growth Health sector gets Rs. 15,291 crore in budget Domestic pharma firms perform well in third − Nutraceuticals market in India to grow − Alkem healths plan Rs 25 cr investment − Government focuses on polio eradication in − 11 cases of polio detected this year − World population will reach 9.2 billion by 2050 − Glenmark’s Argentina subsidiary gives positive − Neurological disorders affect millions globally: − Canada & Gates foundation launches new HIV Regulatory News
− WHO reports some promising results on avian − Budget proposals announced for 2007-08 Product News
Global News
− Cipla enters agreement with DNDi for anti- Industry Highlights, April 2007
April 2007
− Govt. unlikely to accept Mashelkar view on − Ethypharm in licensing deal with Shantha − Indian laws does not comply with IPR: Novartis − Glaxo new cancer drug gets USFDA approval − Rejecting patents on chemical derivatives − Ranbaxy targets US for $2b sales from generic − EU, US shows concern over public health − Ranbaxy arm gets nod for 20 products − Indian patents act does not violate trips, govt − DCGI approves Bentley’s nasulin trial in India − Strides Arcolab gets US FDA nod for ARV − Ranbaxy suit in US for delay in launch of − Merck & Co’s new HIV treatment shows − Pfizer challenges Ranbaxy against Caduet − Pharma claims 10.4% of all worldwide patent − Sanofi-Aventis to launch fixed dose anti- − US patent office rejects Genetech’s Cabilly II − Indian drug cos focus on new molecules − Pfizer sues Ranbaxy on patent infringement R&D News
− Glanmark in pact with Dyax for research Parliament News
− GVK Bio enters into JV with INC research Lok Sabha
− Novozymes to set up R&D centre in Bangalore − Nicholas Piramal to invest $50m in contract − R&D proposals signed at Bio-Asia 2007 − Regulatory delay hit clinical research firms − Polio cases − Aswagandha for treatment of HIV/AIDS Biotechnology
Indian biotech sector achieves 35% growth − Biocon subsidiary enters R&D pact with Rajya Sabha
− Biotech firms mixed reactions on budget − Biocon to invest rs. 1000 cr. in Andhra Pradesh − Measures taken for surveillance of leprosy − Geovax’s HIV vaccine shows promise in phase − National plan for advanced TB control − First recombinant polyclonal antibody enter − US promotes biogenerics introduction − Recent Indian patents in the field of drugs & Views expressed in the journal are those of the authors and the Editorial Board/Publisher takes no responsibility for the same. We are a secondary abstracting service and the veracity of information is of the source quoted and not our primary responsibility. Industry Highlights, April 2007

Source: http://cdriindia.org/I42007contentpage.pdf


Br J Sports Med 2001; 35 :342–343 Phenylethylamine, a possible link to theantidepressant eVects of exercise? Abstract patients who are insensitive to conventional Objectives —To determine in this pilot study whether aerobic exercise aVects In view of the links between exercise and phenylacetic acid concentration in the depression, and phenylethylamine and depres-sion, the re


Cerebral Cortex , 11(12):1144–9, 2001. Dendritic Inhibition Enhances Neural Coding Properties M. W. Spratling and M. H. Johnson Centre for Brain and Cognitive Development, Birkbeck College, London. UK. Abstract The presence of a large number of inhibitory contacts at the soma and axon initial segment of cortical pyra-midal cells has inspired a large and influential class of neural ne

Copyright © 2012-2014 Medical Theses